A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread

Invasion and Metastasis

Volumn 18, Issue 4, 1998, Pages 192-197

  Moore, Anna ^a   Sergeyev, Nikolay ^a   Bredow, Sebastian ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer; Lymph nodes; Lymphotropic drugs; Metastasis

Indexed keywords

GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG DEVELOPMENT; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MEASUREMENT; MOUSE; NONHUMAN; PARAAORTIC LYMPH NODE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032248283     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024512     Document Type: Article

References (17)

1. Dowlatshahi K, Fan M, Snider H, Habib F: Lymph node micrometastases from breast carcinoma. Cancer 1997;80:1188-1197.
2. McLeskey S, Zhang L, Trock B, et al: Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br J Cancer 1996;73: 1053-1062.
3. Naito Y, Kimura S, Yoshizawa M, Ohtake K, Nakajima T, Saku T: Effects of the anticancer drug cocktail 'UFT' on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model. Oral Oncol 1998; 34:326-331.
4. Weissleder R, Elizondo G, Wittenberg J, Lee A, Josephson L, Brady T: Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
5. Weissleder R, Heautot J, Schaefer B, et al: MR lymphography: Study of a high-efficiency lymphotrophic agent. Radiology 1994;191:225-230.
6. Harisinghani M, Saini S, Weissleder R, et al: MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation. Am J Roentgenol 1999;172: 1347-1351.
7. Doherty N, Beaver T: Comparison of the anaphylactoid response induced in rats by castanospermine and dextran. Int Arch Allergy Appl Immunol 1990;93:19-25.
8. Fidler I: Selection of successive tumor lines for metastasis. Nature New Biol 1973;242:148-149.
9. Fidler I: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975;35:218-224.
10. Fidler I, Hart I: The development of biological diversity and metastatic potential in malignant melanoma. Oncol Dev Biol Med 1982;4:161-176.
11. Nathanson S, Haas G, Mead M, Lee M: Spontaneous regional lymph node metastases of three variants of the B16 melanoma: Relationship to primary tumor size and pulmonary metastases. J Surg Oncol 1986;33: 41-45.
12. Pezzella K, Neville M, Huang J: In vivo inhibition of tumor growth of B16 melanoma by recombinant interleukin 1β. Cytokines 1990;2:357-362.
13. Shrayer D, Bogaars H, Hearing V, Maizel A, Wanebo H: Further characterization of a clinically relevant model of melanoma metastasis as an effective vaccine. Cancer Immunol Immunother 1995;40:277-282.
14. Haas J, Park EC, Seed B: Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 1996;6:315-324.
15. Miyoshi H, Smith K, Mosier D, Verma I, Torbett B: Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283:682-686.
16. Moore A, Marecos E, Simonova M, Weissleder R, Bogdanov A: Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. Microvasc Res 1998;56: 145-153.
17. Lee A, Weissleder R, Brady T, Wittenberg J: Lymph nodes: Microstructural anatomy at MR imaging. Radiology 1991;178:519-522.